A key goal of the Mass General Research Institute is to increase the number of collaborations between our researchers and members of the pharmaceutical and biotech industries.

Historically, there has been a gap between academic research and industry development, as the cultures and work models have been different.

We are working to close that gap by:

  • Creating new training programs in translational research (teaching our investigators how to interact with industry)
  • Collaborating in early-stage translation through our Strategic Alliances initiative
  • Opening the Translational Research Center, an 18-bed in-patient facility for proof-of-concept clinical trials
  • Creating a series of "Think Tanks" that bring together researchers, venture capitalists and members of industry to brainstorm solutions for challenges in rare diseases, neurodegeneration and other key areas of need

The Translational Research Center

  • This $11M facility is an 18-bed, state-of-the-art clinical research space in the heart of the Mass General campus
  • It fully staffed by experienced nurse practitioners, clinical research nurses and support staff
  • By conducting their studies at the TRC, industry members can gain access to Mass General clinicians and investigators, many of whom are leading experts in biomarkers, imaging, molecular biology, drug development and other crucial areas of biomedical research
  • The TRC also provides access to the comprehensive assessment and monitoring resources of Mass General such as novel laboratory tests, radiology department PET scanning and other imaging studies that are not typically available in typical phase 1 facilities

Learn more about the TRC

Strategic Alliances Initiative

  • The Strategic Alliances initiative is focused on early stage translational research and designed to match the research push from the labs at Mass General with the market pull of industry
  • Our goals are to facilitate new funding and collaborative agreements and to create new teaching and training programs for our researchers and members of industry alike
  • Strategic Alliances are cross-departmental, multi-specialty teams of researchers brought together to address major clinical and scientific problems in the areas of epigenetics, neuroinflammation and neurodegeneration, cancer immunology and the microbiome
  • The goal of the initiative is to create productive relationships between academia and industry along the entire translational pipeline:
    • Basic research
    • Proof of concept
    • Development
    • Transfer
  • These efforts are guided by the Research Institute Advisory Council, which comprises key leaders from the biomedical and venture capital fields

Learn more about Strategic Alliances

Back to Top